Form 4: Raphael Pharmaceutical Inc. Director Eliya Yehuda Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Eliya Yehuda reports acquiring 150,000 shares of Raphael Pharmaceutical Inc. common stock at $0.40 per share and disposing of 352,000 shares.
Summary
- On November 25, 2023, Eliya Yehuda, a director of Raphael Pharmaceutical Inc., acquired 150,000 shares of common stock at a price of $0.40 per share.
- On the same day, Eliya Yehuda disposed of 352,000 shares of common stock.
- The reported transaction was filed on March 25, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. The acquisition could be seen as positive, but the disposal offsets this.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities.
Stakeholder Impact
- The transaction may influence investor perception of the company's stock.
Key Dates
| Date | Description |
|---|---|
| 11/25/2023 | Date of stock acquisition and disposal. |
| 03/25/2024 | Date of Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Director, Stock Transaction, Common Stock, RAPH, Raphael Pharmaceutical Inc., Eliya Yehuda
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.